Trials / Unknown
UnknownNCT05981313
Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia
Evaluation of Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Hasan Kalyoncu University · Academic / Other
- Sex
- Male
- Age
- 4 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
The aim of our study is to evaluate the viscoelastic properties of lower extremity muscles in patients with hemophilia A and hemophilia B secondarily to compare them with their healthy peers.
Detailed description
Hemophilia is a rare inherited coagulation disorder that develops as a result of factor VIII (hemophilia A) or factor IX (hemophilia B) deficiency, and is a chronic group of diseases that mainly manifests with intra-articular (hemarthrosis) and intramuscular (hematoma) bleeding, affecting quality of life. The presence of easy ecchymosis formation in early childhood, especially intra-articular and intramuscular spontaneous bleeding, interventions and a history of bleeding that lasted longer than expected after trauma should suggest hemophilia. The severity of bleeding findings is directly related to the degree of deficiency of hemophilia A and B. Hemarthroses due to bleeding in the joint (80%) and hematomas due to intramuscular bleeding (20%) cause joint degeneration and muscle atrophy. The joint in which hemarthrosis is most common is the knee joint, however, bleeding into the lower extremity muscles seriously affects the activities of daily living and lower extremity functionality. For this reason, the researchers aimed to evaluate the viscoelastic properties of lower extremity muscles in hemophilia patients and, secondarily, to compare them with their healthy peers.
Conditions
Timeline
- Start date
- 2023-08-15
- Primary completion
- 2023-08-16
- Completion
- 2023-12-30
- First posted
- 2023-08-08
- Last updated
- 2023-08-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05981313. Inclusion in this directory is not an endorsement.